Verogen a proven leader in equipping forensic science laboratories and criminal investigators to use next-generation sequencing (NGS) to gain deeper insights Addition of Verogen strengthens QIAGEN leadership in fast-growing field of Human ID / forensics anchored by sample collection and preparation, genetic testing analysis and workflow automation Deal builds on partnership launched in 2021 to distribute […]
• FiberSmart® is Genomic Vision’s Artificial Intelligence (AI) powered and fully integrated software automating genomic analysis • FiberSmart® leverages cutting-edge AI to rapidly analyze DNA replication kinetics and provide a seamless user experience • FiberSmart platform was successfully tested by AstraZeneca and the Fritz Lipmann Institute Bagneux (France) – Genomic Vision (FR0011799907 – GV, – […]
Novogene announced the addition of Illumina’s latest high-throughput sequencing system NovaSeq™ X Plus and PacBio’s Revio™ long-read sequencing system to its lineup of sequencing platforms. These systems will be deployed in Novogene’s regional lab facilities and will be available to its global customer base. Novogene is a trusted genomics partner to scientists worldwide and provides access to the latest genomics tools […]
Dublin, Ireland: ERS Genomics announced that its first Canadian patent, CA 2872241, with broad claims to compositions and methods of using CRISPR/Cas9 in humans, animals, plants, and microbes has been granted to the CVC group. CVC stands for University of California, University of Vienna, and Emmanuelle Charpentier and is the acronym used to describe the […]
Partnership to leverage the Helix® Laboratory Platform powered by QIAGEN’s biopharma relationships, NGS capabilities, and global regulatory expertise Addressing health burden in neuro-degenerative diseases, cardio-vascular diseases, and auto-immune and inflammatory diseases that affect hundreds of millions globally Combined offerings include accelerated patient recruitment, real world evidence and diagnostic solutions using NGS and PCR technologies VENLO, Netherlands […]
Innovative chemistries enable simultaneous genomic and epigenomic profiling on the same sample, yielding greater insights for precision medicine SANTA CLARA, Calif.–Agilent Technologies Inc. (NYSE: A) today announced the acquisition of Avida Biomed, an early-stage life sciences company that develops high-performance target enrichment workflows with unique capabilities for clinical researchers utilizing next-generation sequencing (NGS) approaches to […]
Enhanced DNA Interpretation, Dropout Modelling Among Latest Improvements Following extensive technical development and testing, STRmix™ version 2.10 – the latest iteration of the breakthrough software used by forensic analysts to resolve mixed DNA profiles previously considered too complex to interpret – has been launched. Like its predecessors, the newest version of STRmix™ will enable forensic […]
NORTHAMPTON, MA — When Gloucester Marine Genomics Institute (GMGI) was founded in 2013, it already had an Illumina connection-it was created with help from Illumina co-founder David Walt. Now Illumina provides in-kind donations to support its mission. Gloucester is one of several communities on Cape Ann, Massachusetts, north of Boston. The region had a thriving fishing industry for hundreds […]
Addition of next generation sequencing research panels, bioinformatics, positions IDT to become a leading oncology research solutions provider Coralville, IA — Integrated DNA Technologies, Inc. (IDT) today announced it closed on the purchase of Next Generation Sequencing (NGS) research assays from Invitae Corporation (NYSE: NVTA) under the trademarked name Archer®. The integration of IDT’s portfolio […]
— Invitae will continue to invest in its precision oncology focused lab developed test (LDT) offerings — — The transaction contributes to Invitae’s cash runway and includes a strategic supply partnership to support the growth of Invitae Personalized Cancer Monitoring™ (PCM) services — SAN FRANCISCO — Invitae (NYSE: NVTA), a leading medical genetics company, today announced […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
